Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olmesartan Medoxomil Tablets

Approval Number

国药准字H20223232

Company青岛黄海制药有限责任公司

Registration Date

April 19, 2022

Drug Information

Generic Name

奥美沙坦酯片

Dosage Form

片剂

Strength

40mg

Drug Type

化学药品

Registration Date

April 19, 2022

Company Information

Applicant Company

Company Name青岛黄海制药有限责任公司

Company Address

青岛市崂山区科苑经四路17号

Manufacturing Company

Company Name青岛黄海制药有限责任公司

Company Address

青岛市崂山区科苑经四路17号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

奥美沙坦酯片 - NMPA 批准文号 | MedPath